INTRODUCTION
A number of receptors retain their ability to recognize their corresponding ligands after electrophoretic separation ofproteins and blotting to nitrocellulose membrane [1] . Several lipoprotein receptor types, including the low-density lipoprotein (LDL) receptor [2] , acetyl-LDL (scavenger) receptor [3] , high-density lipoprotein (HDL) receptor [4] [5] [6] and LDL-receptor-related protein [7] , have been detected by this ligand-blotting method. In each case the binding characteristics obtained in ligand-blotting studies closely resembled those determined in studies in intact cells, thus validating the use of ligand-blotting in the characterization of lipoprotein-binding proteins.
Several studies have recently demonstrated that lipoproteins are capable of eliciting intracellular signalling responses in a variety of cell types, including platelets, fibroblasts, endothelial cells and vascular smooth-muscle cells (VSMC) (reviewed in [8] ). The responses elicited by lipoproteins are dose-dependent and saturable, indicating the probable, but not yet proven, involvement of specific receptors/binding sites in lipoprotein-stimulated signal transduction. Studies in cultured VSMC have also demonstrated that LDL-stimulated signalling is heparin-insensitive and involves a pertussis-toxin-sensitive guanine-nucleotide-binding protein (G-protein) [9] , characteristics which would indicate that the signal-transduction-coupled LDL-recognition site is quite distinct from the 'classical' LDL receptor.
In order to investigate the existence of atypical lipoproteinbinding proteins in vascular smooth muscle, this study has applied the ligand-blotting method for characterization of lipoprotein-binding proteins in membranes isolated from de-endothelialized human medial aortic tissue. We demonstrate that these membranes contain a major lipoprotein-binding protein with a molecular mass of approx. 105 kDa, the properties of creased in the presence of high density lipoprotein (HDL), although more than 100-fold molar excess of HDL was required to achieve 50 % displacement of bound LDL. The LDL-binding activity of 105 kDa protein was inhibited by EDTA, and was also significantly decreased when samples were reduced by /lmercaptoethanol before electrophoresis. Monoclonal 
METHODS Preparation of lipoproteins
LDL (density 1.019-1.063 g/ml) and HDL3 (density 1.125-1.215 g/ml) were isolated from the plasma of healthy male humans by using sequential buoyant-density centrifugation techniques, with use of NaBr for density adjustments [9, 10] . Apolipoprotein (apo) E-free HDL (HDL3) was prepared from total HDL fraction (density 1.063-1.20 g/ml) by heparin-agarose affinity chromatography [11, 12] . LDL preparations were free of protein fragments known to be generated during LDL oxidation [13] . LDL was acetylated (acetyl-LDL) as described by Basu et al. [14] , and carbamoylated (carbamoyl-LDL) as described by Weisgraber et al. [15] . Complete chemical modification of LDL was validated by enhanced anodic electrophoretic mobility under non-denaturing conditions, as well as by the lack of ability to compete with native LDL for binding to the apo B,E receptor of fibroblasts (see the Results section, Figure 8 ). LDL was iodinated by the ICI method [16] . Protein concentrations were determined by the Lowry method, with BSA as standard.
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Y. S. Kuzmenko and others adventitial layer, homogenized (Polytron) in ice-cold solution containing 250 mM sucrose, 0.05 % (w/v) BSA, 1 mM phenylmethanesulphonyl fluoride (PMSF), 20 mM 3-(N-morpholino)-propanesulphonic acid (pH 7.4 at 4°C), and centrifuged at 1000 g for 10 min at 4 'C. The supernatant was filtered through cheesecloth and centrifuged at 10000 g for O min at 4 'C. The resulting supernatant was centrifuged at 112000 g for 30 min at 4 'C, and the pellet was suspended in BSA-free homogenization solution. Confluent and quiescent cultures of human microarteriolar VSMC [18] were rinsed with PBS before being scraped into lysis buffer, containing 2 mM EDTA, 20 mM Tris/HCl (pH 7.4), 2 ,ug/ml leupeptin, 2 ,ug/ml aprotinin and 1 mM PMSF. After sonication, cell lysates were centrifuged at 100000 g for 30 min at 4 'C. The resulting pellets were suspended in 250 mM sucrose/i mM PMSF/20 mM 3-(N-morpholino)-propanesulphonic acid (pH 7.4 at 4 C). Medial and VSMC membrane preparations were divided into batches and stored in liquid N2, and protein concentrations were determined by the Lowry method, with BSA as standard.
Preparation of partially purified apo B,E receptors Solubilization and partial chromatographic purification of apo B,E receptor from human liver and bovine adrenal cortex was performed as described [19] . These preparations were generously given by Dr. V. Tsibulsky, Cardiology Research Center, Moscow, Russia.
Culture of fibroblasts and competition binding
Conditions for 1251I-LDL binding to confluent and quiescent cultures of human skin fibroblasts [20] have been detailed previously [9] . Briefly, the binding of 1251-LDL (at 5,ug/ml), without or with inclusion of unlabelled native LDL, acetyl-LDL or carbamoyl-LDL, was carried out for 4 h at 4 'C in Dulbecco's modified Eagle's medium containing 0.1 % BSA. Non-specific binding of 1251I-LDL was determined by including excess (I mg/ml) unlabelled LDL in parallel series of dishes. After washing, monolayers were incubated in the presence of heparin (10 mg/ml), and the displaced radioactivity was taken as the measure of binding to apo B,E receptor [16] . SDS/PAGE, ligand blotting and immunoblotting Unless otherwise specified (Figure 4) , PAGE was performed under non-reducing conditions. Portions of membrane preparations were solubilized in sample buffer without ,-mercaptoethanol and heated for 5 (Figure 4a) , and the 105 kDa band could be detected at concentrations of LDL as low as 1 ,tg/ml (Figure 4c) . The concentration-dependent profile for LDL binding to 105 kDa protein in aortic membranes is comparable with that previously found for 125I-LDL binding to cultured VSMC [9] . (Figure 7 ). Selective chemical modification (e.g. acetylation, carbamoylation) of lysine residues in LDL abolishes binding to apo B,E receptor [27] . This has been demonstrated by both ligand-blotting studies on membrane preparations [2] and binding studies in cell cultures [14, 16, 28] . The inability of anionized LDL to bind to apo B,E receptor is illustrated in the competition-binding experiment presented in Figure 8 (a), whereby in cultured quiescent fibroblasts native LDL fully competed for bound 1251-LDL (heparin-releasable), whereas displacement of 1251-LDL by either acetyl-LDL or carbamoyl-LDL was negligible. However, in ligand-blot experiments on aortic medial membranes we found that, like native LDL, both acetyl-LDL and carbamoyl-LDL those used in this study) was determined to be -515-600 kDa [7] . Another lipoprotein receptor capable of lipoprotein binding on ligand blots is the scavenger receptor [3] . However, this receptor has an electrophoretic mobility corresponding to a molecular mass of -260 kDa [3] , and does not recognize native LDL [27] . Furthermore Another type of lipoprotein receptor which can specifically recognize HDL has been found previously in several cell types, including VSMC [12] . It was demonstrated that this receptor selectively binds HDL and that expression of specific HDL binding can be enhanced by pretreatment of cells with cholesterol [35] . An HDL-binding protein, with an apparent molecular mass of 105-110 kDa and which can be up-regulated by cholesterol, has been detected by ligand blotting [6] . Clearly, the size of this HDL receptor is very close to that of the lipoprotein-binding protein detected in human aortic media membranes. However, several characteristics of the lipoprotein-binding activity of 105 kDa protein, including a significant selectivity for LDL (100-fold molar excess of HDL3 produces only 2-fold decrease in LDL binding), a prominent loss of binding activity after reduction of disulphide bonds, and a dependence on bivalent cations, contrast with the previously established properties of the HDL receptor [4] [5] [6] 12, 35, 36] .
Studies in hepatoma cells have revealed the existence of another lipoprotein-binding protein, identified as nucleolin or a nucleolinlike protein which is partially expressed on the cell surface [37] . The similarities of nucleolin to the 105 kDa lipoprotein-binding protein in aortic membranes include its molecular mass (-. 109 kDa), a greater selectivity for LDL (compared with HDL) and a lower affinity (compared with apo B,E receptor) for LDL. However, in contrast with LDL-binding activity of 105 kDa protein, the LDL-binding activity of nucleolin is insensitive to both EDTA and thiol-group-reducing agents [37] .
Another lipoprotein-binding protein of interest is lipoprotein lipase (LPL), an essential enzyme of lipid metabolism and a normal constituent of the arterial wall. LPL has been shown to enhance binding of lipoproteins to cells and the extracellular matrix, probably by mediating bridge formation between lipoprotein particles and cell-surface/extracellular-matrix-contained [38] [39] [40] . Although LPL is primarily located on the luminal endothelial cell surface of the vessel wall [41] , it can also be transported across the endothelial cell layer via both nonspecific fluid-phase transcytosis and a specific saturable transport system [42] . Additionally, aortic smooth-muscle cells have been shown to express LPL mRNA [43] . We can, however, confidently exclude the participation of LPL in the major lipoproteinbinding activity of our de-endothelialized aortic membrane preparations, since not only does LPL have a markedly lower molecular mass (50 kDa) [44] , but LPL-mediated LDL binding is almost completely independent of Ca2l [40] .
Arterial-wall sulphated proteoglycans (PGs), complex macromolecules in which sulphated glycosaminoglycan (GAG) chains are linked to a protein core, are also capable of binding lipoproteins [45] . The binding of LDL to sulphated PGs is believed to occur via ionic interactions between the negatively charged sulphate groups in the saccharide units of GAGs and the positively charged lysine and arginine residues of apo B-100 [46, 47] . LDL is able to interact with several arterial-wall PGs, including the dermatan sulphate, heparan sulphate and chondroitin sulphate types, and even within the same PG/GAG family there is considerable heterogeneity with respect to size, charge and polysaccharide content [46, 48] . Since we consistently detected only one major lipoprotein-binding band on ligand blots, a participation of PG/GAG interactions in the lipoproteinbinding activity of 105 kDa protein appears most unlikely. Additionally, binding of LDL to PGs/GAGs is strongly dependent on ionic strength, with complete inhibition at concentrations of NaCl greater than -0.15 M [47, 49] . This feature contrasts starkly with the minimal effect of 0.5 M CaC12 on 105 kDa-protein LDL-binding activity. Some of the features described here, of lipoprotein binding to the 105 kDa protein in aortic membranes, are generally regarded as characteristic of specific lipoprotein receptors. These include lipoprotein selectivity, a dependence on bivalent cations and the requirement for a certain tertiary protein structure. Nevertheless, in a comparative appraisal of the present and previously published data, it is evident that the spectrum of properties of the 105 kDa lipoprotein-binding protein is distinct from those of previously identified lipoprotein-binding molecules. At present we cannot conclude that the 105 kDa protein is a completely novel lipoprotein-binding molecule, and must still consider that it could represent a modification of some known lipoprotein receptor.
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